ASWE:XETRA:XETRA-Saturna Al-Kawthar Global Focused Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 9.002

Change

+0.03 (+0.32)%

Market Cap

USD 0.01B

Volume

470.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.45 (-0.85%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.14 (-0.82%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.24 (-0.85%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.26 (-0.90%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.23 (-0.91%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.22 (-0.48%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-1.56 (-1.10%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.45 (-0.86%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.11 (+0.10%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.50 (+0.08%)

USD 80.38B

ETFs Containing ASWE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.14% 80% B- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.14% 80% B- 75% C
Trailing 12 Months  
Capital Gain 22.19% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.19% 74% C 74% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.05% 61% D- 61% D-
Dividend Return 9.05% 60% D- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.18% 62% D 70% C-
Risk Adjusted Return 88.90% 80% B- 82% B
Market Capitalization 0.01B 8% B- 8% B-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.